Dabomb Protein (6578) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.000x

Based on the latest financial reports, Dabomb Protein (6578) has a cash flow conversion efficiency ratio of 0.000x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-354.00K ≈ $-11.15K USD) by net assets (NT$989.28 Million ≈ $31.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Dabomb Protein liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Dabomb Protein - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Dabomb Protein's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dabomb Protein Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dabomb Protein ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Harn Engineering Solutions Public Company Limited
BK:HARN
0.006x
Apex Equity Holdings Bhd
KLSE:5088
-0.044x
Estrella Resources Ltd
AU:ESR
-0.064x
P&K Skin Research Center Co. Ltd
KQ:347740
0.021x
Team Young Advanced Technology Co Ltd
TWO:5345
-0.242x
Apollo Sindoori Hotels Limited
NSE:APOLSINHOT
0.001x
Compumedics Ltd
AU:CMP
0.129x
The Beachbody Company, Inc.
NASDAQ:BODI
-0.038x

Annual Cash Flow Conversion Efficiency for Dabomb Protein (2015–2025)

The table below shows the annual cash flow conversion efficiency of Dabomb Protein from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Dabomb Protein market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$989.28 Million
≈ $31.17 Million
NT$16.65 Million
≈ $524.44K
0.017x -61.46%
2024-12-31 NT$1.09 Billion
≈ $34.32 Million
NT$47.55 Million
≈ $1.50 Million
0.044x +542.86%
2023-12-31 NT$958.06 Million
≈ $30.18 Million
NT$6.51 Million
≈ $204.97K
0.007x -74.94%
2022-12-31 NT$727.20 Million
≈ $22.91 Million
NT$19.71 Million
≈ $620.85K
0.027x +141.29%
2021-12-31 NT$674.24 Million
≈ $21.24 Million
NT$-44.25 Million
≈ $-1.39 Million
-0.066x -442.83%
2020-12-31 NT$700.51 Million
≈ $22.07 Million
NT$13.41 Million
≈ $422.52K
0.019x -59.80%
2019-12-31 NT$698.39 Million
≈ $22.00 Million
NT$33.26 Million
≈ $1.05 Million
0.048x +53.30%
2018-12-31 NT$710.52 Million
≈ $22.39 Million
NT$22.07 Million
≈ $695.42K
0.031x -55.90%
2017-12-31 NT$622.77 Million
≈ $19.62 Million
NT$43.87 Million
≈ $1.38 Million
0.070x -26.73%
2016-12-31 NT$619.77 Million
≈ $19.53 Million
NT$59.58 Million
≈ $1.88 Million
0.096x -59.24%
2015-12-31 NT$592.64 Million
≈ $18.67 Million
NT$139.78 Million
≈ $4.40 Million
0.236x --

About Dabomb Protein

TWO:6578 Taiwan Packaged Foods
Market Cap
$37.51 Million
NT$1.19 Billion TWD
Market Cap Rank
#23015 Global
#1444 in Taiwan
Share Price
NT$16.55
Change (1 day)
+0.61%
52-Week Range
NT$14.65 - NT$25.55
All Time High
NT$32.11
About

DaBomb Protein Biotech Corp. manufactures and sells hydrolyzed soy protein in Vietnam, the Philippines, South Korea, Taiwan, and Asia. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising Liqui-TIDE bandages. The company was formerly known as DaBomb Protein Corp. and changed its n… Read more